| 标题 |
2023 Phase 1 trial of HS006, a recombinant human-mouse chimeric anti-CD20 monoclonal antibody to treat CD20 positive B-cell non-Hodgkin’s lymphoma in China
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
| 其它 |
这是参考文献引用,实在搜不到了 Li Z, Wang Y, Sun P, et al. 2023 Phase 1 trial of HS006, a recombinant human-mouse chimeric anti-CD20 monoclonal antibody to treat CD20 positive B-cell non-Hodgkin’s lymphoma in China. J Cancer14:2263-73. |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)